Mumbai, Maharashtra, 25th of February, 2026 : In a significant step toward combating resistant hypertension, Gleneagles Hospital in Parel has launched a dedicated Renal Denervation Therapy Centre in collaboration with Medtronic India. The centre is specially designed for patients whose blood pressure remains uncontrolled despite multiple medications — a condition known as resistant hypertension.
Equipped with advanced technology, the facility will conduct comprehensive evaluations for every patient. Specialists will review ongoing medications, make necessary adjustments, and, when required, recommend Renal Denervation Therapy. The objective is not merely to lower blood pressure, but to significantly reduce the risk of heart attack, stroke, and kidney failure.
Director and Cardiologist Dr. Rahul Gupta explains, “Resistant hypertension is often silent, yet its consequences can be life-threatening. Renal Denervation Therapy offers a new ray of hope for such patients.”
Nephrologist Dr. Bharat Shah adds, “Uncontrolled blood pressure can cause permanent kidney damage over time. Timely intervention is crucial to prevent long-term complications.”
CEO Dr. Bipin Chevale emphasizes that “Patient-centric care and consistent follow-ups are the keys to sustainable blood pressure control.” Meanwhile, Managing Director Mandeep Singh Kumar of Medtronic India notes, “Greater awareness combined with advanced treatment solutions can effectively address the growing challenge of resistant hypertension.”
At a time when stress, unhealthy eating habits, and sedentary lifestyles are increasingly common, this initiative is being viewed as a vital step toward protecting the heart and kidneys of Mumbai’s residents.
About The Author
More Stories
1,000 Leaders. 400 Brands. One Blueprint. India’s Retail Decade Starts Now.
HD Kumaraswamy Highlights Resilient Financing Ecosystem At CE Finance Conclave.
South Africa Strengthens Workforce Readiness Ahead Of Critical Minerals Boom.